EU Healthcare, Pharmaceuticals & Life Sciences Regulations & EMA Decisions
Comprehensive intelligence on EU pharmaceutical package reforms, EMA marketing authorisations, MDR/IVDR compliance, European Health Data Space, and HERA crisis measures in the OJ L series.
Healthcare, Pharmaceuticals & Life Sciences Regulatory Landscape & Compliance Overview
Official IntelligencePolicyIndex indexes real-time gazette notifications, policy orders, tariff determinations, and compliance circulars issued across the Healthcare, Pharmaceuticals & Life Sciences sector. Regulatory intelligence is aggregated across central ministries, state regulatory commissions, and statutory authorities.
Statutory Directives
Official Extraordinary Gazettes, S.O. & G.S.R. orders, and executive notifications.
Compliance Mandates
Sector-specific regulatory obligations, licensing norms, and statutory filing guidelines.
Specialized Healthcare, Pharmaceuticals & Life Sciences Verticals
Looking for Weekly Policy & Regulatory Briefings?
Access curated sector roundups, executive summaries, and downloadable PDF intelligence reports.
Official Healthcare, Pharmaceuticals & Life Sciences Gazettes & Notifications
Frequently Asked Questions on Healthcare, Pharmaceuticals & Life Sciences Regulations
Which EU bodies regulate pharmaceuticals and medical devices?
The European Commission (DG SANTE) proposes health legislation. The European Medicines Agency (EMA) evaluates human and veterinary medicinal products. Medical devices are evaluated by national designated Notified Bodies and coordinated through the Medical Device Coordination Group (MDCG).
What is the European Health Union and what legislation underpins it?
The European Health Union is a policy framework comprising the HERA authority for health emergency preparedness, Regulation (EU) 2022/2371 on serious cross-border health threats, strengthened mandates for the EMA and ECDC, the European Health Data Space (EHDS), and the proposed pharmaceutical legislation revision.